Related
ICICI Securities has buy call on with a target price of Rs 193. The current market price of Aster DM Healthcare Ltd. is Rs 156.5. Time period given by analyst is one year when Aster DM Healthcare Ltd. price can reach defined target.
Aster DM Healthcare Ltd., incorporated in the year 2008, is a Mid Cap company (having a market cap of Rs 7794.90 Crore) operating in Hospitals & Allied Services sector.
Financials
For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 2420.69 Crore, up 6.89 % from last quarter Total Income of Rs 2264.57 Crore and up 3.98 % from last year same quarter Total Income of Rs 2327.94 Crore. Company reported net profit after tax of Rs 116.27 Crore in latest quarter.
Investment Rationale
The brokerage cuts revenue and EBITDA estimates by 1-2% and 5-6% respectively for FY22-FY23 to factor in impact of 2nd COVID-19 wave. It maintains BUY with a revised SoTP-based target price of Rs193/share based on FY23E (earlier: Rs200/share). Key downside risks: Regulatory hurdles, delay in recovery post COVID-19 and delay in turnaround of new hospitals.
Promoter/FII Holdings
Promoters held 37.9 per cent stake in the company as of March 31, 2021, while FIIs held 8.9 per cent, DIIs 7.8 per cent and public and others 42.8 per cent.
Aster DM Healthcare Ltd., incorporated in the year 2008, is a Mid Cap company (having a market cap of Rs 7794.90 Crore) operating in Hospitals & Allied Services sector.
Financials
For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 2420.69 Crore, up 6.89 % from last quarter Total Income of Rs 2264.57 Crore and up 3.98 % from last year same quarter Total Income of Rs 2327.94 Crore. Company reported net profit after tax of Rs 116.27 Crore in latest quarter.
Investment Rationale
The brokerage cuts revenue and EBITDA estimates by 1-2% and 5-6% respectively for FY22-FY23 to factor in impact of 2nd COVID-19 wave. It maintains BUY with a revised SoTP-based target price of Rs193/share based on FY23E (earlier: Rs200/share). Key downside risks: Regulatory hurdles, delay in recovery post COVID-19 and delay in turnaround of new hospitals.
Did you Know?
Stock score of Aster DM Healthcare Ltd moved up by 2 in a month on a 10-point scale.
View Latest Stock Report »Promoter/FII Holdings
Promoters held 37.9 per cent stake in the company as of March 31, 2021, while FIIs held 8.9 per cent, DIIs 7.8 per cent and public and others 42.8 per cent.
(Disclaimer: Views and recommendations given in this section are the analysts' own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
